Lv11
28 积分 2025-04-24 加入
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
8小时前
已完结
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2
26天前
已完结
Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer
26天前
已完结
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma
26天前
已完结
皖公网安备34019202002308
